News Release

We donated to an organization that conducts international ophthalmology support activities in collaboration with 11 social partners.

The National Institute of Biomedical Innovation, Health and Nutrition, Plantex, and Rohto Pharmaceutical have signed a joint research agreement on the cultivation of medicinal plants in plant factories.

Rohto Pharmaceutical and Oishii Plus have signed a capital and business alliance agreement.

Goals for 2030 in non-financial areas (environment/society) "Sustainability Goals 2030"

Developed our proprietary program, "Rohto Medical Care Method™". Launched the new brand "Dermacept RX" series, ensuring that functional cosmetics are used correctly and appropriately.

Fujita Academy and Rohto Pharmaceutical Co., Ltd. establish a joint venture and enter the real world data business.

Courtesy visit to the Governor of Tottori Prefecture. Introducing "KING KUROME," a food product made with seaweed (kurome) from Tottori Prefecture.

"MELANO CC Deep Clear Enzyme Facial Wash" surpasses 2 billion yen in sales! A hit product following its serum!

Bofu-tsusho-san has been confirmed to have an "inhibitory effect on sugar (fructose) absorption"!

With a new selling point of "removing excess sugar," Rohto Bofu Tsusho San Tablets (Full Dose a) have evolved into a new product that is easier to try, easier to take, and easier to continue using!